[Cinacalcet in the therapy of secondary hyperparathyroidism--own experiences].


UNLABELLED Secondary hyperparathyroidism (sHPT) affects 20-25% dialysed patients and is related to the bone, mineral and cardiovascular complications. Cinacalcet, acts on the calcium-sensing receptor increasing its sensitivity to calcium, thereby reducing parathyroid hormone (PTH) secretion. The aim of this study was to evaluate the effect of cinacalcet in… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.